nach oben

Erschienen in:

19.11.2016

Results of a Randomized Open Multicenter Comparative Study of the Tolerability and Safety of Gilenya (fingolimod) in Patients with Remitting Multiple Sclerosis (the GIMN study)

verfasst von: E. V. Popova, A. N. Boiko, O. V. Boiko, (for the study group)

Einloggen, um Zugang zu erhalten

Titel: Results of a Randomized Open Multicenter Comparative Study of the Tolerability and Safety of Gilenya (fingolimod) in Patients with Remitting Multiple Sclerosis (the GIMN study)
verfasst von: E. V. Popova
A. N. Boiko
O. V. Boiko
(for the study group)
Publikationsdatum: 19.11.2016
Verlag: Springer US
Erschienen in: Neuroscience and Behavioral Physiology / Ausgabe 1/2017
Print ISSN: 0097-0549
Elektronische ISSN: 1573-899X
DOI: https://doi.org/10.1007/s11055-016-0370-2